ENGOT-en9/LEAP-001: A phase 3 study of first-line pembrolizumab plus lenvatinib compared with chemotherapy in advanced or recurrent endometrial cancer Meeting Abstract
| Authors: | Randall, L.; Marth, C.; Vulsteke, C.; Jesús Rubio, M.; Makker, V.; Braicu, I.; McNeish, I.; Madry, R.; Ayhan, A.; Hasegawa, K.; Wu, X.; Dutta, L.; Xu, C.; Keefe, S.; Lee, J.; Pignata, S. |
| Abstract Title: | ENGOT-en9/LEAP-001: A phase 3 study of first-line pembrolizumab plus lenvatinib compared with chemotherapy in advanced or recurrent endometrial cancer |
| Meeting Title: | 2020 xDigital Annual Global Meeting of the International Gynecologic Cancer Society (IGCS) |
| Journal Title: | International Journal of Gynecological Cancer |
| Volume: | 30 |
| Issue: | Supp. 3 |
| Meeting Dates: | 2020 Sep 10-13 |
| Meeting Location: | Virtual Conference |
| ISSN: | 1048-891X |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2020-11-01 |
| Start Page: | A130 |
| Language: | English |
| ACCESSION: | WOS:000616549600276 |
| PROVIDER: | wos |
| DOI: | 10.1136/ijgc-2020-IGCS.277 |
| Notes: | Meeting Abstract: 323; Poster IGCS20_1346 -- Source: Wos |
